Actual survival, in days, of NOD-SCID mice in latent infection model
NOD-SCID latent infection model . | Survival, d . | Log-rank P compared to PDC-depleted PBMCs group . | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
1 . | 2 . | 3 . | 4 . | 5 . | 6 . | 7 . | 8 . | Median . | ||
PDC-depleted PBMCs | 31 | 35 | 36 | 37 | 49 | 49 | 51 | 58 | 43 | |
PBMCs alone | 33 | 51 | 51 | 68 | 76* | 100 | > 120 | > 120 | 72 | .02 |
PDC-enriched PBMCs | 39 | 44 | 51 | 71 | 90 | 123 | 193 | 197 | 80 | .01 |
IFN-α-pulsed PBMCs | 51 | 52 | 58 | 65 | 65 | 69 | 128 | 160 | 65 | .03 |
NOD-SCID latent infection model . | Survival, d . | Log-rank P compared to PDC-depleted PBMCs group . | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
1 . | 2 . | 3 . | 4 . | 5 . | 6 . | 7 . | 8 . | Median . | ||
PDC-depleted PBMCs | 31 | 35 | 36 | 37 | 49 | 49 | 51 | 58 | 43 | |
PBMCs alone | 33 | 51 | 51 | 68 | 76* | 100 | > 120 | > 120 | 72 | .02 |
PDC-enriched PBMCs | 39 | 44 | 51 | 71 | 90 | 123 | 193 | 197 | 80 | .01 |
IFN-α-pulsed PBMCs | 51 | 52 | 58 | 65 | 65 | 69 | 128 | 160 | 65 | .03 |
n = 8 for each group; total n = 32.
Evidence of tumors at autopsy.